Tauns Laboratories (TSE:197A) Accounts Payable & Accrued Expense : 円3,286 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Accounts Payable & Accrued Expense?

Tauns Laboratories's quarterly accounts payable & accrued expense declined from Mar. 2024 (円6,264 Mil) to Jun. 2024 (円4,307 Mil) and declined from Jun. 2024 (円4,307 Mil) to Dec. 2024 (円3,286 Mil).

Tauns Laboratories's annual accounts payable & accrued expense declined from Jun. 2022 (円6,434 Mil) to Jun. 2023 (円1,636 Mil) but then increased from Jun. 2023 (円1,636 Mil) to Jun. 2024 (円4,307 Mil).

Tauns Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for Tauns Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Accounts Payable & Accrued Expense Chart

Tauns Laboratories Annual Data

Trend

Jun22

Jun23

Jun24

Accounts Payable & Accrued Expense

6,434.49

1,636.10

4,306.95

Tauns Laboratories Quarterly Data
	Jun22	Jun23	Mar24	Jun24	Dec24
Accounts Payable & Accrued Expense	6,434.49	1,636.10	6,263.69	4,306.95	3,285.64

Tauns Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Tauns Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325

Website

https://www.tauns.co.jp/en

Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines